Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses NWFL in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named NWFL in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| James Donnelly | $605,000 | $151,250 | $198,200 | $0 | $0 | $0 | $55,334 | $1,009,784 |
| President and Chief Executive Officer | ||||||||
| John McCaffery | 350,200 | 136,000 | 59,600 | 0 | 0 | 0 | 39,928 | 585,728 |
| Executive Vice President, Chief Financial Officer | ||||||||
| John Carmody | 260,000 | 94,130 | 44,700 | 0 | 0 | 0 | 56,626 | 455,456 |
| Executive Vice President, Chief Credit Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| James Donnelly | $1,009,784 | $874,697 | — | +135,087 |
| John McCaffery | 585,728 | — | — | — |
| John Carmody | 455,456 | 291,658 | — | +163,798 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| James A. Shook | Director | 2026-04-10 | A | 45 | $30 | $1,368 | Common | Form 4 ↗ |
| Jeffrey S. Gifford | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Spencer J. Andress | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Ronald R. Schmalzle | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Kevin M. Lamont | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Alexandra K. Nolan | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Ralph A. Matergia | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Meg L. Hungerford | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Dr. Marissa Nacinovich | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Dr. Kenneth A. Phillips | Director | 2026-04-10 | A | 45 | 30 | 1,368 | Common | Form 4 ↗ |
| Dr. Andrew A. Forte | Director | 2026-04-10 | A | 55 | 30 | 1,671 | Common | Form 4 ↗ |
| James O. Donnelly | Director | 2026-04-29 | A | 100 | 29 | 2,906 | Common | Form 4 ↗ |
| James A. Shook | Director | 2026-04-30 | A | 375 | 29 | 10,898 | Common | Form 4 ↗ |
| John McCaffery | EVP & CFO | 2026-04-30 | A | 1,000 | 29 | 29,440 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-05-01 | A | 180 | 30 | 5,330 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-05-05 | A | 76 | 29 | 2,239 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-05-05 | A | 96 | 29 | 2,828 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-05-05 | A | 24 | 29 | 706 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-05-05 | A | 100 | 29 | 2,944 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-05-05 | A | 100 | 29 | 2,942 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-05-05 | A | 276 | 29 | 8,131 | Common | Form 4 ↗ |
| Jeffrey S. Gifford | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Alexandra K. Nolan | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Meg L. Hungerford | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Dr. Andrew A. Forte | Director | 2026-05-11 | A | 270 | 30 | 7,987 | Common | Form 4 ↗ |
| Spencer J. Andress | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Dr. Marissa Nacinovich | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Ralph A. Matergia | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Kevin M. Lamont | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Dr. Kenneth A. Phillips | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Ronald R. Schmalzle | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| James A. Shook | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-05-11 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Dr. Andrew A. Forte | Director | 2026-05-11 | A | 55 | 30 | 1,661 | Common | Form 4 ↗ |
| Ronald R. Schmalzle | Director | 2026-05-26 | A | 700 | 30 | 21,133 | Common | Form 4 ↗ |
| Ronald R. Schmalzle | Director | 2026-05-26 | A | 700 | 30 | 21,133 | Common | Form 4 ↗ |
| Dr. Kenneth A. Phillips | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Meg L. Hungerford | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Jeffrey S. Gifford | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Dr. Andrew A. Forte | Director | 2026-06-10 | A | 55 | 30 | 1,660 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Spencer J. Andress | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Ralph A. Matergia | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| James A. Shook | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Ronald R. Schmalzle | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Alexandra K. Nolan | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Dr. Marissa Nacinovich | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Kevin M. Lamont | Director | 2026-06-10 | A | 45 | 30 | 1,359 | Common | Form 4 ↗ |
| Ralph A. Matergia | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Dr. Marissa Nacinovich | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Ronald R. Schmalzle | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Kevin M. Lamont | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Meg L. Hungerford | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Dr. Andrew A. Forte | Director | 2026-07-10 | A | 52 | 32 | 1,658 | Common | Form 4 ↗ |
| Spencer J. Andress | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Dr. Kenneth A. Phillips | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Joseph W. Carroll | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| James A. Shook | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Alexandra K. Nolan | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| Jeffrey S. Gifford | Director | 2026-07-10 | A | 43 | 32 | 1,371 | Common | Form 4 ↗ |
| James A. Shook | Director | 2026-07-28 | A | 3,100 | 35 | 107,105 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| James Donnelly | RSA | — | — | — | 6,651 | — | $198,200 |
| John Carmody | RSA | — | — | — | 1,500 | — | 44,700 |
| John McCaffery | RSA | — | — | — | 2,000 | — | 59,600 |
Grant-level vehicle detail not disclosed.
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| John Carmody | RSU | 900 | — | $25,245 |
| John Carmody | RSU | 600 | — | 16,830 |
| James Donnelly | RSU | 4,738 | — | 132,901 |
| James Donnelly | RSU | 1,000 | — | 28,050 |
| John McCaffery | RSU | 1,200 | — | 33,660 |
| John Carmody | RSU | 1,500 | — | 42,075 |
| John McCaffery | RSU | 2,000 | — | 56,100 |
| James Donnelly | RSU | 3,868 | — | 108,497 |
| John Carmody | RSU | 250 | — | 7,012 |
| John Carmody | RSU | 1,200 | — | 33,660 |
| James Donnelly | RSU | 6,651 | — | 186,561 |
| John McCaffery | RSU | 804 | — | 22,552 |
Mr. Donnelly will participate in an equitable manner with all other senior management employees of the Bank and the Company in discretionary incentive compensation that the Boards of Directors of the Bank and the Company may award from time to time their senior management employees.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | True |
| Anti-hedging | False |
| Anti-pledging | False |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-04-28 | 5,282,802 | 802,735 | 237,295 | 86.81% | Passed |
| 2023 | 2023-04-25 | 3,455,075 | 523,762 | 318,740 | 86.84% | Passed |
| 2020 | 2020-05-26 | 3,888,526 | 169,426 | 68,026 | 95.82% | Passed |
| 2017 | 2017-04-25 | 2,190,358 | 172,739 | 131,598 | 92.69% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-04-28 | 86.81%a |
| 2023 | 2023-04-25 | 86.84%b |
| 2020 | 2020-05-26 | 95.82%c |
a. Approved under the standard stated in the filing — “Broker non-votes and abstentions will not be counted as votes cast and will have no effect on the voting on this proposal.”.
b. Approved under the standard stated in the filing — “Broker non-votes and abstentions will not be counted as votes cast and will have no effect on the voting on this proposal.”.
c. Approved under the standard stated in the filing — “Broker non-votes and abstentions will not be counted as votes cast and will have no effect on the voting on this proposal.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Dr. Andrew A. ForteIndependent · Board Chair · Audit · Nominating/Governance | $96,335 | $24,585 | $0 | $0 | $75 | $120,995 |
| Kevin M. LamontIndependent · Compensation · Nominating/Governance | 92,550 | 24,585 | 0 | 0 | 75 | 117,210 |
| Alexandra K. NolanIndependent · Compensation · Nominating/Governance | 92,280 | 24,585 | 0 | 0 | 75 | 116,940 |
| Meg L. HungerfordIndependent · Audit (Chair) | 87,945 | 24,585 | 0 | 0 | 2,842 | 115,372 |
| Jeffrey S. GiffordIndependent · Audit · Compensation | 90,300 | 24,585 | 0 | 0 | 53 | 114,938 |
| Ralph A. MatergiaIndependent · Audit · Compensation · Nominating/Governance | 89,550 | 24,585 | 0 | 0 | 53 | 114,188 |
| Dr. Kenneth A. PhillipsIndependent · Audit | 87,980 | 24,585 | 0 | 0 | 53 | 112,618 |
| Ronald R. SchmalzleIndependent | 86,410 | 24,585 | 0 | 0 | 56 | 111,051 |
| Lewis J. CritelliIndependent · Departed during FY | 77,575 | 3,226 | 0 | 0 | 56 | 80,857 |
| Dr. Marissa NacinovichIndependent · Audit | 21,210 | 24,585 | 0 | 0 | 27 | 45,822 |
| James A. ShookIndependent | 21,210 | 24,585 | 0 | 0 | 27 | 45,822 |
| Susan CampfieldIndependent · Departed during FY | 12,570 | 3,226 | 0 | 0 | 12 | 15,808 |
| James O. DonnellyEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Spencer J. AndressIndependent · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Joseph W. CarrollIndependent · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Annual cash retainer | $66,000 |
|---|---|
| Annual equity retainer | — |
| Per board meeting fee | $785 |
| Committee chair fees (audit / comp / nom-gov) | 3,000 / 1,500 / 1,500 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $855,915 |
| Equity awards (grant-date value) | $252,302 |
| All other compensation | $3,404 |
| Total cost of the board | $1,111,621 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Norwood Financial Corp | 2025 | James Donnelly | $605,000 | $198,200 | $0 | $0 | $1,009,784 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, James Donnelly | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “EXECUTIVE COMPENSATION”. As printed: 1,009,784. Filing ↗machine: t30 · r2 · c31 · span 174499–174508 |
| 2 | Section 01, John McCaffery | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “EXECUTIVE COMPENSATION”. As printed: 585,728. Filing ↗machine: t30 · r5 · c31 · span 180996–181003 |
| 3 | Section 01, John Carmody | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “EXECUTIVE COMPENSATION”. As printed: 455,456. Filing ↗machine: t30 · r7 · c31 · span 185196–185203 |
| 4 | Section 03, James Donnelly RSA | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t30 · r2 · c15 · span 173446–173453 |
| 5 | Section 03, John Carmody RSA | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t30 · r7 · c15 · span 184144–184150 |
| 6 | Section 03, John McCaffery RSA | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “EXECUTIVE COMPENSATION” · grants of plan-based awards table. Filing ↗machine: t30 · r5 · c15 · span 179944–179950 |
| 7 | Section 07, pay ratio | 10-K | 2026-03-13 | 0001013272-26-000003 | Section “CEO Pay Ratio”. As printed: —. Filing ↗ |
| 8 | Section 08, Dr. Andrew A. Forte | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 120,995. Filing ↗machine: t57 · r2 · c19 · span 302548–302555 |
| 9 | Section 08, Kevin M. Lamont | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 117,210. Filing ↗machine: t57 · r5 · c19 · span 307441–307448 |
| 10 | Section 08, Alexandra K. Nolan | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 116,940. Filing ↗machine: t57 · r9 · c19 · span 313915–313922 |
| 11 | Section 08, Meg L. Hungerford | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 115,372. Filing ↗machine: t57 · r4 · c19 · span 305838–305845 |
| 12 | Section 08, Jeffrey S. Gifford | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 114,938. Filing ↗machine: t57 · r8 · c19 · span 312309–312316 |
| 13 | Section 08, Ralph A. Matergia | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 114,188. Filing ↗machine: t57 · r6 · c19 · span 309071–309078 |
| 14 | Section 08, Dr. Kenneth A. Phillips | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 112,618. Filing ↗machine: t57 · r7 · c19 · span 310678–310685 |
| 15 | Section 08, Ronald R. Schmalzle | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 111,051. Filing ↗machine: t57 · r11 · c19 · span 317206–317213 |
| 16 | Section 08, Lewis J. Critelli | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 80,857. Filing ↗machine: t57 · r10 · c19 · span 315600–315606 |
| 17 | Section 08, Dr. Marissa Nacinovich | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 45,822. Filing ↗machine: t57 · r13 · c19 · span 320447–320453 |
| 18 | Section 08, James A. Shook | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 45,822. Filing ↗machine: t57 · r12 · c19 · span 318833–318839 |
| 19 | Section 08, Susan Campfield | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 15,808. Filing ↗machine: t57 · r3 · c19 · span 304206–304212 |
| 20 | Section 08, James O. Donnelly | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 21 | Section 08, Spencer J. Andress | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 22 | Section 08, Joseph W. Carroll | DEF 14A | 2026-03-25 | 0001193125-26-122940 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 23 | Section 02, James A. Shook 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154574 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 24 | Section 02, Jeffrey S. Gifford 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154531 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 25 | Section 02, Joseph W. Carroll 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154564 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 26 | Section 02, Spencer J. Andress 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154535 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Ronald R. Schmalzle 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154523 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Kevin M. Lamont 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154551 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Alexandra K. Nolan 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154516 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Ralph A. Matergia 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154500 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Meg L. Hungerford 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154558 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Dr. Marissa Nacinovich 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154512 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Dr. Kenneth A. Phillips 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154520 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Dr. Andrew A. Forte 2026-04-10 | Form 4 | 2026-04-14 | 0001193125-26-154527 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, James O. Donnelly 2026-04-29 | Form 4 | 2026-04-30 | 0001437749-26-014206 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, James A. Shook 2026-04-30 | Form 4 | 2026-05-01 | 0001437749-26-014359 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, John McCaffery 2026-04-30 | Form 4 | 2026-04-30 | 0001437749-26-014208 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Joseph W. Carroll 2026-05-01 | Form 4 | 2026-05-04 | 0001437749-26-014583 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Joseph W. Carroll 2026-05-05 | Form 4 | 2026-05-06 | 0001193125-26-208391 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Joseph W. Carroll 2026-05-05 | Form 4 | 2026-05-06 | 0001193125-26-208391 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Joseph W. Carroll 2026-05-05 | Form 4 | 2026-05-06 | 0001193125-26-208391 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Joseph W. Carroll 2026-05-05 | Form 4 | 2026-05-06 | 0001193125-26-208391 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Joseph W. Carroll 2026-05-05 | Form 4 | 2026-05-06 | 0001193125-26-208391 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Joseph W. Carroll 2026-05-05 | Form 4 | 2026-05-06 | 0001193125-26-208391 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Jeffrey S. Gifford 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221126 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Alexandra K. Nolan 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221221 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Meg L. Hungerford 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221110 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Dr. Andrew A. Forte 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221143 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Spencer J. Andress 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221182 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Dr. Marissa Nacinovich 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221235 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Ralph A. Matergia 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221243 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Kevin M. Lamont 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221271 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Dr. Kenneth A. Phillips 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221207 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Ronald R. Schmalzle 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221204 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, James A. Shook 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221195 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Joseph W. Carroll 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221156 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Dr. Andrew A. Forte 2026-05-11 | Form 4 | 2026-05-13 | 0001193125-26-221143 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Ronald R. Schmalzle 2026-05-26 | Form 4 | 2026-05-26 | 0001193125-26-239068 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 02, Ronald R. Schmalzle 2026-05-26 | Form 4 | 2026-05-27 | 0001193125-26-240663 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 60 | Section 02, Dr. Kenneth A. Phillips 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268724 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 61 | Section 02, Meg L. Hungerford 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268651 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 62 | Section 02, Jeffrey S. Gifford 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268639 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 63 | Section 02, Dr. Andrew A. Forte 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268631 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 64 | Section 02, Joseph W. Carroll 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268628 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 65 | Section 02, Spencer J. Andress 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268625 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 66 | Section 02, Ralph A. Matergia 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268670 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 67 | Section 02, James A. Shook 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268731 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 68 | Section 02, Ronald R. Schmalzle 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268666 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 69 | Section 02, Alexandra K. Nolan 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268717 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 70 | Section 02, Dr. Marissa Nacinovich 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268711 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 71 | Section 02, Kevin M. Lamont 2026-06-10 | Form 4 | 2026-06-12 | 0001193125-26-268657 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 72 | Section 02, Ralph A. Matergia 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303096 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 73 | Section 02, Dr. Marissa Nacinovich 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303086 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 74 | Section 02, Ronald R. Schmalzle 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303062 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 75 | Section 02, Kevin M. Lamont 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303119 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 76 | Section 02, Meg L. Hungerford 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303124 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 77 | Section 02, Dr. Andrew A. Forte 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303135 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 78 | Section 02, Spencer J. Andress 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303148 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 79 | Section 02, Dr. Kenneth A. Phillips 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303070 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 80 | Section 02, Joseph W. Carroll 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303144 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 81 | Section 02, James A. Shook 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303057 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 82 | Section 02, Alexandra K. Nolan 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303082 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 83 | Section 02, Jeffrey S. Gifford 2026-07-10 | Form 4 | 2026-07-14 | 0001193125-26-303130 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 84 | Section 02, James A. Shook 2026-07-28 | Form 4 | 2026-07-30 | 0001193125-26-325161 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 85 | Section 06, 2026 vote | Form 8-K | 2026-05-04 | 0001193125-26-203951 | Item 5.07 · say-on-pay result. As reported: 86.81% (votes for as printed: 5,282,802). Filing ↗ |
| 86 | Section 06, 2023 vote | Form 8-K | 2023-04-28 | 0001193125-23-124513 | Item 5.07 · say-on-pay result. As reported: 86.84% (votes for as printed: 3,455,075). Filing ↗ |
| 87 | Section 06, 2020 vote | Form 8-K | 2020-05-27 | 0001193125-20-153215 | Item 5.07 · say-on-pay result. As reported: 95.82%. Filing ↗ |
| 88 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 89 | Section 09b board cost (computed) | Computed | — | computed | Cash 855,915 + equity 252,302 + all other 3,404 = 1,111,621, summed across the director compensation table rows.machine: formula: Σ = 1,111,621 |
| 90 | Norwood Financial Corp (subject), Section 10b CEO total | DEF 14A | 2026-03-25 | 0001193125-26-122940 | CEO total compensation as printed in Norwood Financial Corp's own proxy. As printed: 1,009,784. Filing ↗machine: t30 · r2 · c31 · span 174499–174508 |